#precision_longevity
Peptide Therapies May Get Easier to Get. Should You Care?
Written by
The FDA is weighing legal access to BPC-157, TB-500, and other peptides. Easier access is not the same as proven efficacy – here is what the evidence actually says. Read more…
Why Your Walking Speed Might Be a Brain-Health Signal
Written by
A study of adults 80+ found the fastest walkers had roughly half the cognitive decline risk of the slowest. Here is what that correlation actually means. Read more…
This Month in Longevity Research: Cartilage and Funding
Written by
A microRNA that protects cartilage under load, and a new nonprofit betting on unglamorous basic aging research – this month’s longevity science roundup. Read more…
Which Workout Actually Lowers Your Inflammation?
Written by
A network meta-analysis of 55 trials shows resistance and aerobic training lower different inflammatory markers – pick your modality accordingly. Read more…
Why Heart Disease Prevention Is an Aging Problem
Written by
A geroscience review argues cardiovascular disease should be treated as an aging problem, not an isolated condition – with healthspan as the real goal. Read more…
Could Existing Drugs Already Be Slowing Aging?
Written by
A network-medicine study maps existing, already-approved drugs onto the Hallmarks of Aging to find faster longevity-drug candidates. Read more…
